| Follow Us: Facebook Twitter

News

Ann Arborís CytoPherx raises largest VC in state since 2009

Want to read a big number? $34 million is a pretty big number, isn't it? That's how much CytoPhrex has raised in venture capital, which pretty much sets the record for 2011. And 2010 for that matter.

Excerpt:

"Ann Arbor-based CytoPherx Inc., a clinical-stage medical device company initially focused on acute kidney failure, announced today that it has raised $34 million in venture capital, the largest round of such funding for a state company since Ann Arbor-based Lycera Corp. raised $36 million in April 2009."

Read the rest here.
Signup for Email Alerts
Signup for Email Alerts

Related Company

  • CytoPherx
    206 S 5th St
    Suite 550
    Ann Arbor, MI 48104 Website
    CytoPherx, founded in July 2007 and headquartered in Ann Arbor, is a venture-backed, clinical stage medical device company addressing inflammation-based diseases and conditions with a proprietary selective cytopheresis system.